Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Sales | 20,835 | 18,475 | 24,229 | 24,329 | 22,800 |
| Cost of Goods | 15,146 | 17,599 | 17,767 | 19,787 | 18,768 |
| Gross Profit | 5,689 | 875 | 6,462 | 4,542 | 4,032 |
| Operating Expenses | 7,037 | 1,975 | 1,953 | 1,433 | 1,457 |
| Operating Income | -1,348 | -1,100 | 4,509 | 3,109 | 2,575 |
| Interest Expense | 33 | 29 | 29 | 204 | 184 |
| Other Income | 5,288 | 0 | -5,294 | -3,188 | -1 |
| Pre-tax Income | 3,906 | -1,129 | -814 | -284 | 2,390 |
| Income Tax | 1,259 | -196 | 1,391 | -85 | 337 |
| Net Income Continuous | 2,648 | -933 | -2,205 | -198 | 2,053 |
| Net Income | $2,648 | $-933 | $-2,205 | $-198 | $2,053 |
| EPS Basic Total Ops | 0.11 | -0.04 | -0.09 | -0.01 | 0.09 |
| EPS Basic Continuous Ops | 0.11 | -0.04 | -0.09 | -0.01 | 0.09 |
| EPS Diluted Total Ops | 0.11 | -0.04 | -0.09 | -0.01 | 0.09 |
| EPS Diluted Continuous Ops | 0.11 | -0.04 | -0.09 | -0.01 | 0.09 |
| EBITDA(a) | $5,393 | $435 | $1,169 | $1,418 | $4,371 |